In-Syringe Electrokinetic Protein Removal from Biological Samples prior to Electrospray Ionization Mass Spectrometry.
Ibraam E MikhailMasoomeh TehranirokhAndrew A GooleyRosanne M GuijtMichael C BreadmorePublished in: Angewandte Chemie (International ed. in English) (2020)
Here, an electrokinetic extraction (EkE) syringe is presented allowing for on-line electrokinetic removal of serum proteins before ESI-MS. The proposed concept is demonstrated by the determination of pharmaceuticals from human serum within minutes, with sample preparation limited to a 5× dilution of the sample in the background electrolyte (BGE) and application of voltage, both of which can be performed in-syringe. Signal enhancements of 3.6-32 fold relative to direct infusion of diluted serum and up to 10.8 fold enhancement, were obtained for basic and acidic pharmaceuticals, respectively. Linear correlations for the basic drugs by EkE-ESI-MS/MS were achieved, covering the necessary clinical range with LOQs of 5.3, 7.8, 6.1, and 17.8 ng mL-1 for clomipramine, chlorphenamine, pindolol, and atenolol, respectively. For the acidic drugs, the EkE-ESI-MS LOQs were 3.1 μg mL-1 and 2.9 μg mL-1 for naproxen and paracetamol, respectively. The EkE-ESI-MS and EkE-ESI-MS/MS methods showed good accuracy (%found of 81 % to 120 %), precision (≤20 %), and linearity (r>0.997) for all the studied drugs in spiked serum samples.
Keyphrases
- ms ms
- liquid chromatography tandem mass spectrometry
- mass spectrometry
- capillary electrophoresis
- ionic liquid
- liquid chromatography
- high performance liquid chromatography
- gas chromatography
- ultra high performance liquid chromatography
- low dose
- multiple sclerosis
- high resolution
- binding protein
- small molecule
- solid phase extraction
- solid state
- high resolution mass spectrometry